Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ze Hong

Showing results (341-350 of 379) with videos related to

Pageof 38
Sort By:
Expert Review of Vaccines|December 25, 2024
Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged ≥18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trialBei-Fang Yang, Jing Jin, Xi-Ran He, et al.
Molecular Cancer Therapeutics|November 21, 2007
MFTZ-1, an actinomycetes subspecies derived antitumor macrolide, functions as a novel topoisomerase II poisonCheng-Ying Xie, Hong Zhu, Li-Ping Lin, et al.
Cell Death & Disease|August 1, 2025
CHK1 inhibition increases the therapeutic response to radiotherapy via antitumor immunity in ARID1A-deficient colorectal cancerJhen-Yu Chen, Tao-Wei Ke, Shu-Fen Chiang, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2024
Activation of STING by the novel liposomal TLC388 enhances the therapeutic response to anti-PD-1 antibodies in combination with radiotherapyJhen-Yu Chen, Po-Yu Lin, Wei-Ze Hong, et al.
World Journal of Gastroenterology|June 26, 2007
Tc-99m ciprofloxacin imaging in acute cholecystitisYun-Mee Choe, Wonsick Choe, Keon-Young Lee, et al.
Biochemical Pharmacology|October 30, 2024
ITFG2 as a NEDD4-2 inhibitor: Preserving calcium homeostasis to prevent myocardial ischemic injuryFu Liu, Li-Fang Lv, Fang-Fang Bi, et al.
European Journal of Pharmacology|March 31, 2022
Montelukast, cysteinyl leukotriene receptor 1 antagonist, inhibits cardiac fibrosis by activating APJYun Wu, Chen Cui, Fang-Fang Bi, et al.
Cancer Immunology, Immunotherapy : CII|February 25, 2026
Heterologous prime-boost immunization of AAV-based neoantigen cancer vaccine induces anti-tumor immunity to inhibit tumor growth and relapseChi-Hsien Huang, Jhen-Yu Chen, Hsin-Yu Chang, et al.
Cancer Letters|November 15, 2025
Targeting DRP1 promotes radiotherapy-induced antitumor immunity via mitochondrial DNA-mediated cGAS-STING signaling in KRAS-mutated colorectal cancerYuan-Yao Tsai, Hsin-Yu Chang, Wei-Ze Hong, et al.
BMJ Open|July 14, 2025
Rheumatoid Arthritis Real-world Cohort Study in China (ReALSA): protocol for a multicentre prospective, longitudinal cohort studyJian-Zi Lin, Yingying Zhu, Qian-Hua Li, et al.
Pageof 38

Showing results (341-350 of 379) with videos related to

Sort By:
Pageof 38
Expert Review of Vaccines|December 25, 2024
Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged ≥18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trialBei-Fang Yang, Jing Jin, Xi-Ran He, et al.
Molecular Cancer Therapeutics|November 21, 2007
MFTZ-1, an actinomycetes subspecies derived antitumor macrolide, functions as a novel topoisomerase II poisonCheng-Ying Xie, Hong Zhu, Li-Ping Lin, et al.
Cell Death & Disease|August 1, 2025
CHK1 inhibition increases the therapeutic response to radiotherapy via antitumor immunity in ARID1A-deficient colorectal cancerJhen-Yu Chen, Tao-Wei Ke, Shu-Fen Chiang, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2024
Activation of STING by the novel liposomal TLC388 enhances the therapeutic response to anti-PD-1 antibodies in combination with radiotherapyJhen-Yu Chen, Po-Yu Lin, Wei-Ze Hong, et al.
World Journal of Gastroenterology|June 26, 2007
Tc-99m ciprofloxacin imaging in acute cholecystitisYun-Mee Choe, Wonsick Choe, Keon-Young Lee, et al.
Biochemical Pharmacology|October 30, 2024
ITFG2 as a NEDD4-2 inhibitor: Preserving calcium homeostasis to prevent myocardial ischemic injuryFu Liu, Li-Fang Lv, Fang-Fang Bi, et al.
European Journal of Pharmacology|March 31, 2022
Montelukast, cysteinyl leukotriene receptor 1 antagonist, inhibits cardiac fibrosis by activating APJYun Wu, Chen Cui, Fang-Fang Bi, et al.
Cancer Immunology, Immunotherapy : CII|February 25, 2026
Heterologous prime-boost immunization of AAV-based neoantigen cancer vaccine induces anti-tumor immunity to inhibit tumor growth and relapseChi-Hsien Huang, Jhen-Yu Chen, Hsin-Yu Chang, et al.
Cancer Letters|November 15, 2025
Targeting DRP1 promotes radiotherapy-induced antitumor immunity via mitochondrial DNA-mediated cGAS-STING signaling in KRAS-mutated colorectal cancerYuan-Yao Tsai, Hsin-Yu Chang, Wei-Ze Hong, et al.
BMJ Open|July 14, 2025
Rheumatoid Arthritis Real-world Cohort Study in China (ReALSA): protocol for a multicentre prospective, longitudinal cohort studyJian-Zi Lin, Yingying Zhu, Qian-Hua Li, et al.
Pageof 38